Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.

British journal of haematology - 1 Mar 2018

Di Napoli Arianna, Jain Preti, Duranti Enrico, Margolskee Elizabeth, Arancio Walter, Facchetti Fabio, Alobeid Bachir, Santanelli di Pompeo Fabio, Mansukhani Mahesh, Bhagat Govind

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA (Cytosine-5-)-Methyltransferases
Share to DNA Methyltransferase 3A
Share to Frameshift Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Janus Kinases

Share to Lymphoma, Large-Cell, Anaplastic

Share to STAT3 Transcription Factor

Share to Suppressor of Cytokine Signaling 1 Protein

Source

Identifiers

PMID: 27859003
DOI: 10.1111/bjh.14431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.PMID 27859003Read ↗

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.Semantic proximity Read ↗

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaSemantic proximity Read ↗

Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.Semantic proximity Read ↗

Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.Semantic proximity Read ↗

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).Semantic proximity Read ↗

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.Semantic proximity Read ↗

BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations.Semantic proximity Read ↗

[Advancement of next generation sequencing in breast cancer].Semantic proximity Read ↗

Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.Semantic proximity Read ↗

The Cancer Genome Atlas: clinical applications for breast cancer.Semantic proximity Read ↗

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications.Semantic proximity Read ↗

Molecular characterization of metaplastic breast carcinoma via next-generation sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.